BUZZ-Ebola treatment developers: Stocks continue to rise

Wed Oct 1, 2014 7:28am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Stocks of five drugmakers with potential Ebola treatments up premarket

** Canadian drugmaker Tekmira Pharmaceutical's U.S.-listed shares up 32 pct; BioCryst Pharmaceuticals Inc up 15 pct; Sarepta Therapeutics Inc up 7.8 pct; Newlink Genetics Corp up 12 pct; Inovio Pharmaceuticals Inc up 10.8 pct

** U.S. Centers for Disease Control and Prevention confirmed the first case of the virus diagnosed in the United States on Tuesday